NCT04985981

Brief Summary

The Prediction of Anastomotic Insufficiency risk after Colorectal surgery (PANIC) study aims to establish a machine-learning-based application that allows for accurate preoperative prediction of patients at risk for anastomotic insufficiency after colon and colorectal surgery.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
11,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Apr 2021

Geographic Reach
1 country

2 active sites

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2021

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 2, 2021

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
Last Updated

December 1, 2021

Status Verified

November 1, 2021

Enrollment Period

1.8 years

First QC Date

July 22, 2021

Last Update Submit

November 26, 2021

Conditions

Keywords

Anastomotic Leak

Outcome Measures

Primary Outcomes (1)

  • Occurrence of Anastomotic leak

    Occurrence of anastomotic insufficiency/leak is defined as any clinical signs of leakage, confirmed by radiological examination, endoscopy, clinical examination of the anastomosis, or upon reoperation.

    5 years

Secondary Outcomes (2)

  • Occurrence of Death

    90 days

  • Time to diagnosis of anastomotic leak

    90 days

Other Outcomes (5)

  • Disease-free survival (months)

    5 years

  • Overall survival (months)

    5 years

  • Adjuvant/additive immunochemotherapy (yes/no)

    5 years

  • +2 more other outcomes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who underwent colon or colorectal anastomosis for neoplasia, diverticulitis, mesenterial ischemia, iatrogenic or traumatic perforation, or inflammatory bowel disease. Only patients who have reached the age of 18 will be accepted. Only patients who are able to give informed consent to the procedure will be accepted.

You may qualify if:

  • Patients who underwent colon or colorectal anastomosis for neoplasia, diverticulitis, mesenterial ischemia, iatrogenic or traumatic perforation, or inflammatory bowel disease

You may not qualify if:

  • age \< 18
  • recurrent colorectal cancer
  • peritoneal carcinomatosis or unresectable metastatic disease at time of bowel resection
  • informed consent not obtainable
  • follow-up \< 6 weeks after surgery
  • no reversal of and ostomy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Clinical Research and Artificial Intelligence in Surgery, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland

Allschwil, Basel, 4123, Switzerland

Location

Kantonsspital Winterthur

Winterthur, Canton of Zurich, 8401, Switzerland

Location

MeSH Terms

Conditions

Anastomotic LeakColorectal NeoplasmsDiverticulumCrohn DiseaseColitis, UlcerativeMesenteric Ischemia

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesDiverticular DiseasesGastroenteritisPathological Conditions, AnatomicalInflammatory Bowel DiseasesColitisPeritoneal DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Michel Adamina, Prof. Dr. med.

    Clinical Research and Artificial Intelligence in Surgery, Department of Biomedical Engineering, University of Basel, Allschwil, Switzerland

    STUDY CHAIR
  • Anas Taha, Dr. med.

    None currently

    PRINCIPAL INVESTIGATOR
  • Thomas Steffen

    Cantonal Hospital of St. Gallen

    PRINCIPAL INVESTIGATOR
  • Stephanie Taha-Mehlitz, Dr. med.

    Department of Visceral Surgery, Clarunis, University Hospital Basel, Basel, Switzerland

    PRINCIPAL INVESTIGATOR
  • Frédéric Ris, Prof. Dr. med.

    Department of Surgery, Hôpitaux Universitaires de Genève

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chefarzt

Study Record Dates

First Submitted

July 22, 2021

First Posted

August 2, 2021

Study Start

April 1, 2021

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

December 1, 2021

Record last verified: 2021-11

Locations